Biochemistry of Epstein—Barr Virus

  • Elliott Kieff
  • Timothy Dambaugh
  • Walter King
  • Mark Heller
  • Andrew Cheung
  • Vicky Van Santen
  • Mary Hummel
  • Christopher Beisel
  • Susan Fennewald
Part of the The Viruses book series (VIRS)


The objective of this introduction is to develop concisely the context in which biochemical studies of Epstein—Barr virus (EBV) have been undertaken. Elements of history and biology are relevant to an understanding of the somewhat unusual course of biochemical research with EBV.


Burkitt Lymphoma Raji Cell Abortive Infection Phosphonoacetic Acid Short Internal Repeat 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams, A., Lindahl, T., and Klein, G., 1973, Linear association between Cellular DNA and Epstein-Barr virus DNA in a human lymphoblastoid Cell line, Proc. Natl. Acad. Sci. U.S.A. 70:2888–2892.PubMedGoogle Scholar
  2. Adams, A., Bjursell, G., Kaschka-Dierich, C., and Lindahl, T., 1977, Circular Epstein-Barr virus genomes of reduced size in a human lymphoid Cell line of infectious mononucleosis origin, J. Virol. 22:373–380.PubMedGoogle Scholar
  3. Alspaugh, M., Jensen, F., Rabin, H., and Tan, E., 1978, Lymphocytes transformed by Epstein-Barr virus: Induction of nuclear antigen reactive with antibody in rheumatoid arthritis, J. Exp. Med. 147:1018–1025.PubMedGoogle Scholar
  4. Andersson-Anvret, M., and Lindahl, T., 1978, Integrated viral DNA sequences in Epstein-Barrvirus-converted human lymphoma lines, J. Virol. 25:710–718.PubMedGoogle Scholar
  5. Baron, D., and Strominger, J., 1978, Partial purification and properties of the EBV associated nuclear antigen, J. Biol. Chem. 253:2875–2881.PubMedGoogle Scholar
  6. Bodemer, W., Summers, W., and Niederman, J., 1980, Detection of virus specific antigens in EB(P3HR-1) virus superinfected Raji cells by immunoprecipitation, Virology 103:340–349.PubMedGoogle Scholar
  7. Bornkamm, G.W., Delius, H., Zimber, U., Hudewentz, J., and Epstein, M.A., 1980, Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs, J. Virol. 35:603–618.PubMedGoogle Scholar
  8. Burkitt, D.P. 1962, A tumor safari in east and Central Africa, Br. J. Cancer 16:379–386.PubMedGoogle Scholar
  9. Catalano, M., Carson, D., Niederman, J., Feorino, P., and Vaughan, J., 1980, Antibody to the rheumatoid arthritis nuclear antigen: Its relationship to in vivo EBV infection, J. Clin. Invest. 65:1238–1245.PubMedGoogle Scholar
  10. Cheung, A., and Kieff, E., 1981, Epstein-Barr virus DNA X: A direct repeat within the internal direct repeat of EBV DNA, J. Virol. 40:501–507.PubMedGoogle Scholar
  11. Cheung, A., and Kieff, E., 1982, Epstein-Barr Virus DNA XI: The nucleotide sequence of the large internal repeat in EBV DNA, J. Virol., in press.Google Scholar
  12. Colby, B.M., Shaw, J.E., Elion, G.B., and Pagano, J.S., 1980, Effect of Acyclovir [9-(2-hy-droxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication, J. Virol. 34:560–568.PubMedGoogle Scholar
  13. Dambaugh, T., 1980, Molecular Cloning of Epstein-Barr virus DNA and analysis of RNA in human Burkitt’s tumor tissue, Ph.D. thesis, University of Chicago.Google Scholar
  14. Dambaugh, T., and Kieff, E., 1982, Two related tandem direct repeat sequences in EBV DNA, J. Virol., in press.Google Scholar
  15. Dambaugh, T., Beisel, C., Hummel, M., King, W., Fennewald, S., Cheung, A., Heller, M., Raab-Traub, N., and Kieff, E., 1980a, Epstein-Barr virus DNA. VII. Molecular Cloning and detailed mapping of EBV (B95–8) DNA, Proc. Natl. Acad. Sci. U.S.A. 77:2999–3003.PubMedGoogle Scholar
  16. Dambaugh, T., Raab-Traub, N., Heller, M., Beisel, C., Hummel, M., Cheung, A., Fennewald, S., King, W., and Kieff, E., 1980b, Variations among isolates of Epstein-Barr virus, Ann. N. Y. Acad. Sci. 602:711–719.Google Scholar
  17. Datta, A.K., Feighny, R.J., and Pagano, J.S., 1980, Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate: Purification and Characterization, J. Biol. Chem. 255(11):5120–5125.PubMedGoogle Scholar
  18. Deinhardt, F., Falk, L., Wolfe, L., Paciza, J., and Johnson, D., 1975, Response of marmosets to experimental infection with Epstein-Barr virus, in: Oncogensis and Herpesviruses II (G. de Thé, M. Epstein, and H. zur Hausen, eds.), pp. 161–168, IARC, Lyon.Google Scholar
  19. Delius, H., and Bornkamm, G.W., 1978, Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and non-transforming virus by partial denaturation mapping of their DNAs, J. Virol. 27:81–89.PubMedGoogle Scholar
  20. Desgranges, C., Wolf, H., de Thé, G., Shanmugaratnam, K., Ellouz, R., Cammoun, N., Klein, G., and zur Hausen, H., 1975, Nasopharyngeal Carcinoma. X. Presence of Epstein-Barr genomes in epithelial cells of tumors from high and medium risk areas, Int. J. Cancer 16:7–15.PubMedGoogle Scholar
  21. Desrosiers, R., Mulder, C., and Fleckenstein, B., 1979, Methylation of herpesvirus saimiri DNA in lymphoid tumor Cell lines, Proc. Natl. Acad. Sci. U.S.A. 76:3839–3843.PubMedGoogle Scholar
  22. de-Thé, G., 1979, Demographic studies implicating the virus in the Causation of Burkitt’s lymphoma: Prospects for nasopharyngeal Carcinoma, in: The Epstein-Barr Virus (M. Epstein and B. Achong, eds.), pp. 418–435, Springier-Verlag, Berlin.Google Scholar
  23. Dolyniuk, M., Pritchett, R., and Kieff, E., 1976a, Proteins of Epstein-Barr virus, J. Virol. 17:935–949.PubMedGoogle Scholar
  24. Dolyniuk, M., Wolff, E., and Kieff, E., 1976b, Proteins of Epstein-Barr virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing Components of the enveloped virus, J. Virol. 18:289–297.PubMedGoogle Scholar
  25. Edson, C., and Thorley-Lawson, D., 1981, Epstein-Barr virus membrane antigens: Characterization, distribution and strain differences, J. Virol. 39:172–184.PubMedGoogle Scholar
  26. Einhorn, L., and Ernberg, I., 1978, Induction of EBNA precedes the first Cellular S phase after EBV infection of human lymphocytes, Int. J. Cancer 21:157–160.PubMedGoogle Scholar
  27. Epstein, M.A., and Achong, B.G., 1968, Specific immunofluorescence test for the herpes type EB virus of Burkitt lymphoblasts, authenticated by electron microscopy, J. Natl. Cancer Inst. 40:593–607.PubMedGoogle Scholar
  28. Epstein, M.A., and Achong, B.G., 1970, The EB virus, in: Burkitt’s Lymphoma (D.P. Burkitt and D.H. Wright, eds.), pp. 231–248, Livingstone, Edinburgh.Google Scholar
  29. Epstein, M., and Achong, B.G., 1979, Morphology of the virus and of virus induced Cytopathologic Changes, in: The Epstein-Barr Virus (M. Epstein and B. Achong, eds.), pp. 24–33, Springer-Verlag, Berlin.Google Scholar
  30. Epstein, M.A., Achong, B.G., and Barr, Y., 1964, Virus particules in Cultured lymphoblasts from Burkitt’s lymphoma, Lancet 1:702–703.PubMedGoogle Scholar
  31. Epstein, M.A., Henle, G., Achong, B.G., and Barr, Y.M., 1965, Morphological and biological studies on a virus in Cultured lymphoblasts from Burkitt’s lymphoma, J. Exp. Med. 121:761–770.PubMedGoogle Scholar
  32. Epstein, M.A., Achong, B.G., and Pope, J., 1967, Virus in Cultured lymphoblasts from a New Guinea Burkitt lymphoma, Br. Med. J. 21:290–291.Google Scholar
  33. Epstein, M.A., Hunt, R.D., and Rabin, H., 1973, Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I. Reticuloproliferative disease in an inoculated animal, Int. J. Cancer 12:309–318.PubMedGoogle Scholar
  34. Falk, L., Deinhardt, F., Nonoyama, M., Wolfe, L., and Bergholz, C., 1976, Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus, Int. J. Cancer 18:798–807.PubMedGoogle Scholar
  35. Feighny, R., Farrell, M., and Pagano, J., 1980, Polypeptide synthesis and phosphorylation in EBV infected cells, J. Virol. 34:455–463.PubMedGoogle Scholar
  36. Feighny, R., Henry, B., and Pagano, J., 1981, EBV polypeptides: Effect of inhibition of viral DNA replication in their synthesis, J. Virol. 37:61–71.PubMedGoogle Scholar
  37. Fischer, D., Miller, G., Gradoville, L., Heston, L., Westrate, M., Maris, W., Wright, J., Brandsma, J., and Summers, W., 1981, Genome of a mononucleosis EBV Contains fragments previously regarded to be unique to Burkitt’s lymphoma isolates, Cell 24:543–554.PubMedGoogle Scholar
  38. Fresen, K.O., and zur Hausen, H., 1976, Establishment of EBNA-expressing Cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains, Int. J. Cancer 17:161–166.PubMedGoogle Scholar
  39. Fresen, K.O., and zur Hausen, H., 1977, Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines Converted by Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 74:363–366.PubMedGoogle Scholar
  40. Fresen, K.O., Gho, M.-S., Gissmann, L., and zur Hausen, H., 1979, NC 37-R1 EB-virus: A possible recombinant between intracellular NC 37 viral DNA and superinfecting P3HR-1 EBV, Intervirology 12:303–310.Google Scholar
  41. Furlong, D., Swift, H., and Roizman, B., 1972, Arrangement of herpes virus deoxyribonucleic acid in the Core, J. Virol. 10:1071–1074.PubMedGoogle Scholar
  42. Gerber, P., 1972, Activation of Epstein-Barr virus by 5’-bromo-deoxyuridine in virus free human cells, Proc. Natl. Acad. Sci. U.S.A. 69:83–85.PubMedGoogle Scholar
  43. Gerber, P., and Birch, S.M., 1967, Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt’s lymphoma cells, Proc. Natl. Acad. Sci. U.S.A. 58:478–484.PubMedGoogle Scholar
  44. Gerber, P., and Hoyer, B., 1971, Induction of Cellular DNA synthesis in human leukocytes by Epstein-Barr virus, Nature (London) 231:46–47.Google Scholar
  45. Gerber, P., Whang-Peng, J., and Monroe, J.H., 1969, Transformation and Chromsome Changes induced by Epstein-Barr virus in normal human leukocyte Cultures, Proc. Natl. Acad. Sci. U.S.A. 63:740–747.Google Scholar
  46. Gerber, P., Nkrumah, F., Pritchett, R., and Kieff, E., 1976a, Comparative studies of Epstein-Barr virus strains from Ghana and the United States, Int. J. Cancer 17:71–81.PubMedGoogle Scholar
  47. Gerber, P., Pritchett, R., and Kieff, E., 1976b, Antigens and DNA of a Chimpanzee agent related to Epstein-Barr virus, J. Virol. 19:1090–1100.PubMedGoogle Scholar
  48. Gerber, P., Kalter, S.S., Schidlovsky, G., Peterson, W.D., Jr., and Daniel, M.D., 1977, Biologic and antigenic Characteristics of Epstein-Barr virus-related herpesviruses of Chimpanzees and baboons, Int. J. Cancer 20:448–459.PubMedGoogle Scholar
  49. Gergely, L., Klein, G., and Ernberg, I., 1971, The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines, Int. J. Cancer 7:293–302.PubMedGoogle Scholar
  50. Given, D., and Kieff, E., 1978, DNA of Epstein-Barr virus. IV. Linkage map for restriction enzyme fragments of the B95–8 and W91 strains of EBV, J. Virol. 28:524–542.PubMedGoogle Scholar
  51. Given, D., and Kieff, E., 1979, DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration, J. Virol. 31:315–324.PubMedGoogle Scholar
  52. Given, D., Yee, D., Griem, K., and Kieff, E., 1979, DNA of Epstein-Barr virus. V. Direct repeats at the ends of EBV DNA, J. Virol. 30:852–862.PubMedGoogle Scholar
  53. Glaser, R., and O’Neill, F.J., 1972, Hybridization of Burkitt lymphoblastoid cells, Science 176:1245–1247.PubMedGoogle Scholar
  54. Goldman, N., Landon, H.C., and Reisher, J.I., 1968, Fluorescent antibody and gel diffusion reactions of human and Chimpanzee sera with cells Cultured from Burkitt tumors and normal Chimpanzee blood, Cancer Res. 28:2489–2495.PubMedGoogle Scholar
  55. Graessman, A., Wolf, H., and Bornkamm, G., 1980, Expression of Epstein-Barr virus genes in different cells types after microinjection of viral DNA, Proc. Natl. Acad. Sci. U.S.A. 77:433–436.Google Scholar
  56. Hampar, B., Derge, J.G., Martos, L.M., and Walker, J.L., 1972, Synthesis of Epstein-Barr virus after activation of the viral genome in a “virus-negative” human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine, Proc. Natl. Acad. Sci. U.S.A. 69:78–82.PubMedGoogle Scholar
  57. Hampar, B., Derge, J.G., and Showalter, D.S., 1974a, Enhanced activation of the repressed Epstein-Barr virus genome by inhibitors of DNA synthesis, Virology 58:298–301.PubMedGoogle Scholar
  58. Hampar, B., Derge, J.G., Nonoyama, M., Chang, S.-Y., Tagamets, M., and Showalter, S.D., 1974b, Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine, Virology 62:71–89.PubMedGoogle Scholar
  59. Hampar, B., Tanaka, A., Nonoyama, M., and Derge, J., 1974c, Replication of the resident repressed EBV genome during early S phase (S-1 period) of non-producer Raji cells, Proc. Natl. Acad. Sci. U.S.A. 71:631–633.PubMedGoogle Scholar
  60. Hampar, B., Lenoir, G., Nonoyama, M., Derge, J.G., and Chang, S.-Y., 1976, Cell Cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine, Virology 69:660–668.PubMedGoogle Scholar
  61. Hayward, S.D., and Kieff, E., 1976, Epstein-Barr virus-specific RNA. I. Analysis of viral RNA in Cellular extracts and in the polyribosomal fraction of permissive and nonpermissive lymphoblastoid Cell lines, J. Virol. 18:518–525.PubMedGoogle Scholar
  62. Hayward, S.D., and Kieff, E., 1977, The DNA of Epstein-Barr virus. II. Comparison of the molecular weights of restriction endonuclease fragments of the DNA of strains of EBV and identification of end fragments of the B95–8 strain, J. Virol. 23:421–429.PubMedGoogle Scholar
  63. Hayward, S.D., Pritchett, R., Orellana, T., King, W., and Kieff, E., 1976, The DNA of Epstein-Barr virus fragments produced by restriction enzymes: Homologous DNA and RNA in lymphoblastoid cells, in: Animal Virology, Vol. 4 (D. Baltimore, A. Huang, and C.F. Fox, eds.), pp. 619–639, Academic Press, New York.Google Scholar
  64. Hayward, S., Nogee, L., and Hayward, G., 1980, Organization of repeated regions within the Epstein-Barr virus DNA molecule, J. Virol. 33:507–521.PubMedGoogle Scholar
  65. Heller, M., and Kieff, E., 1981, Co-linearity of Epstein-Barr virus DNA of herpes virus Papio, J. Virol. 37:821–826.PubMedGoogle Scholar
  66. Heller, M., Gerber, P., and Kieff, E., 1982a, The DNA of Herpes Virus Pan, a third member of the Epstein-Barr Virus—Herpes Virus Papco group., J. Virol. 41:931–939.PubMedGoogle Scholar
  67. Heller, M., Dambaugh, T., and Kieff, E., 1981a, Epstein-Barr virus DNA. IX. Variation among viral DNAs, J. Virol. 38:632–648.PubMedGoogle Scholar
  68. Heller, M., Gerber, P., and Kieff, E., 1981b, Herpes virus papio DNA is similar in organization to Epstein-Barr virus DNA, J. Virol. 37:698–709.PubMedGoogle Scholar
  69. Heller, M., van Santen, V., and Kieff, E., 1982b, A simple repeat sequence in Epstein-Barr Virus DNA is transcribed in latent and production infection. J. Virol., in press.Google Scholar
  70. Heller, M., Henderson, A., and Kieff, E., 1982c, A repeat array in Epstein-Barr Virus DNA is related to Cell DNA sequences interspersed on human Chromosomes. Proc. Natl. Acad. Sci. U.S.A., in press.Google Scholar
  71. Henderson, E., Miller, G., Robinson, J., and Heston, L., 1977a, Efficiency of transformation of lymphocytes by Epstein-Barr virus, Virology 76:152–163.PubMedGoogle Scholar
  72. Henderson, E., Robinson, J., Frank, A., and Miller, G., 1977b, Epstein-Barr virus: Transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light, Virology 82:196–205.PubMedGoogle Scholar
  73. Henderson, E., Heston, L., Grogon, E., and Miller, G., 1978, Radiobiologic inactivation of Epstein-Barr virus, J. Virol. 25:51–59.PubMedGoogle Scholar
  74. Henle, G., and Henle, W., 1966, Immunofluorescence in cells derived from Burkitt’s lymphoma, J. Bacteriol. 91:1248–1256.PubMedGoogle Scholar
  75. Henle, W., Diehl, V., Kohn, G., zur Hausen, H., and Henle, G., 1967, Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells, Science 157:1064–1065.PubMedGoogle Scholar
  76. Henle, W., Henle, G., Zajac, B., Pearson, G., Waubke, R., and Scriba, M., 1970, Differential reactivity of human serums with early antigens induced by Epstein-Barr virus, Science 169:188–190.PubMedGoogle Scholar
  77. Hinuma, Y., Konn, M., Yamaguchi, F., Wudarski, D., Blakeslee, J., and Grace, F., 1967, Immunofluorescence and herpes type virus particles in the P3HR-1 Burkitt lymphoma clone, J. Virol. 1:1045–1051.PubMedGoogle Scholar
  78. Hoffman, G., Lazarowitz, S., and Hayward, D., 1980, Monoclonal antibody against a 250,000 dalton glycoprotein of EBV identifies a membrane antigen and a neutralizing antigen, Proc. Natl. Acad. Sci. U.S.A. 77:2979–2983.PubMedGoogle Scholar
  79. Honess, R., and Roizman, B., 1974, Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins, J. Virol. 14:8–18.PubMedGoogle Scholar
  80. Hummel, M., and Kieff, E., 1982, Epstein-Barr Virus RNA VIII. Viral RNA in permissively infected B95–8 Cells. J. Virol., in press.Google Scholar
  81. Hummeler, K., Henle, G., and Henle, W., 1966, Fine structure of a virus in Cultured lymphoblasts from Burkitt lymphoma, J. Bacteriol. 91:1366–1368.PubMedGoogle Scholar
  82. Jehn, U., Lindahl, T., and Klein, G., 1972, Fate of virus DNA in the abortive infection of human lymphoid Cell lines by Epstein-Barr virus, J. Gen. Virol. 16:409.PubMedGoogle Scholar
  83. Jondal, M., and Klein, G., 1973, Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes, J. Exp. Med. 138:1365–1378.PubMedGoogle Scholar
  84. Kallin, B., Luka, J., and Klein, G., 1979, Immunochemical Characterization of Epstein-Barr virus-associated early and late antigens in butyrate treated P3HR-1 cells, J. Virol. 32:710–716.PubMedGoogle Scholar
  85. Kaschka-Dierich, C., Adams, A., Lindahl, T., Bornkamm, G., Bjursell, G., and Klein, G., 1976, Intracellular forms of Epstein-Barr virus DNA in human tumor cells in vivo, Nature (London) 260:302–306.Google Scholar
  86. Kaschka-Dierich, C., Falk, L., Bjursell, G., Adams, A., and Lindahl, T., 1977, Human lymphoblastoid Cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells, Int. J. Cancer 20:173–180.PubMedGoogle Scholar
  87. Kawai, Y., Nonoyama, M., and Pagano, J., 1973, Reassociation kinetics for Epstein-Barr virus DNA: Non-homology to mammalian DNA and homology of viral DNA in various diseases, J. Virol. 12:1006–1012.PubMedGoogle Scholar
  88. Kieff, E., and Levine, J., 1974, Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis, Proc. Natl. Acad. Sci. U.S.A. 71:355–358.PubMedGoogle Scholar
  89. Kieff, E., Raab-Traub, N., Given, D., King, W., Powell, A.T., Pritchett, R., and Dambaugh, T., 1978, Mapping of putative transforming sequences of EBV DNA, in: Oncogenesis and Herpesviruses III (G. de Thé, W. Henle, and F. Rapp, eds.), pp. 527–552, IARC, Lyon.Google Scholar
  90. Kieff, E., Given, D. Powell, A.L.T., King, W., Dambaugh, T., and Raab-Traub, N., Epstein-Barr virus: Structure of the viral DNA and analysis of viral RNA in infected cells, Biochim. Biophys. Acta Rev. 560:355–373.Google Scholar
  91. King, W., Powell, A., Raab-Traub, N., Hawke, M., and Kieff, E., 1980, Epstein-Barr virus RNA. Viral RNA in a restringently infected, growth transformed Cell line, J. Virol. 36:506–518.PubMedGoogle Scholar
  92. King, W., van Santen, V., and Kieff, E., 1981, Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells, J. Virol. 38:649–660.PubMedGoogle Scholar
  93. King, W., Dambaugh, T., Heller, M., Dowling, J., and Kieff, E., 1982, Epstein-Barr Virus DNA XII. A variable region of the EBV genome is included in the P3 HR-1 deletion. J. Virol. 43: in press.Google Scholar
  94. Kintner, C., and Sugden, B., 1979, The structure of the termini of the DNA of Epstein-Barr vims, Cell 17:661–671.PubMedGoogle Scholar
  95. Kintner, C., and Sugden, B., 1981, Conservation and progressive methylation of EBV DNA sequences in transformed cells, J. Virol. 38:305–316.PubMedGoogle Scholar
  96. Klein, G., Giovanella, B.C., Lindahl, T., Fialkow, P.J., Singh, S., and Stehlin, J., 1974, Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with anaplastic Carcinoma of the nasopharynx, Proc. Natl. Acad. Sci. U.S.A. 71:4737–4741.PubMedGoogle Scholar
  97. Klein, G., Svedmyr, E., Jondal, M., and Persson, P., 1976, EBV determined nuclear antigen (EBNA) positive cells in the peripheral blood of infectious mononucleosis patients, Int. J. Cancer 23:746–751.Google Scholar
  98. Landon, J.C., Ellis, L.B., Zene, V.H., and Frabrizio, D.P.A., 1968, Herpes-type virus in Cultured leukocytes from Chimpanzees, J. Natl. Cancer Inst. 40:181–192.PubMedGoogle Scholar
  99. Lee, Y., Tanaka, A., Law, R., Nonoyama, M., and Rabin, H., 1981, Linkage map of the fragments of herpes virus papio DNA, J. Virol. 37:710–720.PubMedGoogle Scholar
  100. Lenoir, G., Bertheion, M.-C, Favre, M.-C, and de Thé, G., 1976, Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the Complement-fixing soluble antigen and relationship with Epstein-Barr virus-associated nuclear antigens, J. Virol. 17:672–674.PubMedGoogle Scholar
  101. Lerner, M., Andrews, N., Miller, G., and Steitz, J., 1981, Two small RNAs encoded by EBV and Complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus, Proc. Natl. Acad. Sci. U.S.A. 78:805–809.PubMedGoogle Scholar
  102. Levy, J.A.S., Levy, S.B., Hirshaut, Y., Kafuko, G., and Prince, A., 1971, Presence of EBV antibodies in sera from wild Chimpanzees, Nature (London) 233:559–560.Google Scholar
  103. Lindahl, T., Adams, A., Bjursell, G., Bornkamm, G.W., Kascha-Dierich, C., and Jehn, U., 1976, Covalently Closed Circular duplex DNA of Epstein-Barr virus in a human lymphoid Cell line, J. Mol. Biol. 102:511–530.PubMedGoogle Scholar
  104. Luka, J., Siegert, W., and Klein, G., 1977, Solubilization of the Epstein-Barr virus-determined nuclear antigen and its Characterization as a DNA-binding protein, J. Virol. 22:1–8.PubMedGoogle Scholar
  105. Luka, J., Lindahl, T., and Klein, G., 1978, Purification of the Epstein-Barr virus-determined nuclear antigen from EBV transformed human lymphoid cells, J. Virol. 27:604–611.PubMedGoogle Scholar
  106. Luka, J., Jornvall, H., and Klein, G., 1980, Purification and biochemical Characterization of the EBV determined nuclear antigen and an associated protein with a 53,000 d subunit, J. Virol. 35:592–602.PubMedGoogle Scholar
  107. Manolov, G., and Manolova, Y., 1972, Marker band in one Chromosome 14 from Burkitt lymphomas, Nature (London) 237:33–34.Google Scholar
  108. Mayyasi, S., Schidlovsky, G., Bulferre, L., and Buschek, F., 1967, Coating reaction of herpes type virus isolated from malignant tissues with an antibody present in sera, Cancer Res. 27:2020–2023.PubMedGoogle Scholar
  109. Menezes, F., Leibold, W., and Klein, G., 1975, Biological differences between different Ep-stein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, Exp. Cell Res. 92:478–484.PubMedGoogle Scholar
  110. Miller, G., and Lipman, M., 1973a, Release of infectious Epstein-Barrvirus by transformed marmoset leukocytes, Proc. Natl. Acad. Sci. U.S.A. 70:190–194.PubMedGoogle Scholar
  111. Miller, G., and Lipman, M., 1973b, Comparison of the yield of infectious virus from Clones of human and simian lymphoblastoid lines transformed by EBV, J. Exp. Med. 138:1398–1412.PubMedGoogle Scholar
  112. Miller, G., Shope, T., Lisco, H., Still, D., and Lipman, M., 1972, Epstein-Barr virus: Transformation Cytopathic Changes, and viral antigens in squirrel monkey and marmoset leukocytes, Proc. Natl. Acad. Sci. U.S.A. 69:383–387.PubMedGoogle Scholar
  113. Miller, G., Robinson, J., Heston, L., and Lipman, M., 1974, Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference, Proc. Natl. Acad. Sci. U.S.A. 71:4006–4010.PubMedGoogle Scholar
  114. Miller, G., Coope, D., Niederman, J., and Pagano, J., 1976, Biological properties and viral surface antigens of Burkitt lymphoma and mononucleosis derived strains of EBV released from transformed marmoset cells, J. Virol. 18:1071–1080.PubMedGoogle Scholar
  115. Moss, D., and Pope, J., 1972, Assay of the infectivity of Epstein-Barr virus by transformation of human leukocytes in vitro, J. Gen. Virol. 17:233–236.PubMedGoogle Scholar
  116. Moss, D., and Pope, F., 1975, EB virus associated nuclear antigen production and Cell proliferation in adult peripheral blood leukocytes inoculated with the QiMR-WIL strain of EB virus, Int. J. Cancer 15:503–511.PubMedGoogle Scholar
  117. Mueller-Lantzsch, N., Yamamoto, N., and zur Hausen, H., 1979, Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation, Virology 97:378–387.PubMedGoogle Scholar
  118. Mueller-Lantzsch, N., Georg, B., Yamamoto, N., and zur Hausen, H., 1980a, Epstein-Barr virus induced proteins. III. Analysis of polypeptides from P3HR-1 EBV-superinfected NC 37 cells by immunoprecipitation, Virology 102:231–233.PubMedGoogle Scholar
  119. Mueller-Lantzsch, N., Georg, B., Yamamoto, N., and zur Hausen, H., 1980b, Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and superinfected cells by immunoprecipitation, Virology 102:401–411.Google Scholar
  120. Neubauer, R., Rabin, B., Strnad, M., Nonoyama, M., and Nelson, R., 1979, Establishment of a lymphoblastoid Cell line and isolation of an Epstein-Barr related virus of gorilla origin, J. Virol. 31:845–853.PubMedGoogle Scholar
  121. Nilsson, K., 1971, High frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood, Int. J. Cancer 8:432–442.PubMedGoogle Scholar
  122. Nilsson, K., Klein, G., Henle, W., and Henle, G., 1971, The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV, Int. J. Cancer 8:443–450.PubMedGoogle Scholar
  123. Nilsson, K., Klein, G., Henle, G., and Henle, W., 1972, The role of EBV in the establishment of lymphoblastoid Cell lines from adult and fetal lymphoid tissue, in: Oncogenesis and Herpesviruses (P.M. Biggs, G. de Thé, and L.N. Payne, eds.), pp. 285–290, IARC, Lyon.Google Scholar
  124. Nonoyama, M., and Pagano, J.S., 1971, Detection of Epstein-Barr viral genome in nonproductive cells, Nature (London) New Biol. 233:103–106.Google Scholar
  125. Nonoyama, M., and Pagano, J.S., 1972, Separation of Epstein-Barr virus DNA from large Chromosomal DNA in non-virus producing cells, Nature (London) New Biol. 238:169–171.Google Scholar
  126. Nonoyama, M., and Pagano, J.S., 1973, Homology between Epstein-Barr virus DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal Carcinoma determined by DNA-DNA reassociation kinetics, Nature (London) 242:44–47.Google Scholar
  127. Nonoyama, M., Huang, C.H., Pagano, J.S., Klein, G., and Singh, S., 1973, DNA of Epstein-Barr virus detected in tissue of Burkitt’s lymphoma and nasopharyngeal Carcinoma, Proc. Natl. Acad. Sci. U.S.A. 70:3265–3268.PubMedGoogle Scholar
  128. O’Conor, G.T., and Rabson, A.S., 1965, Herpes-like particles in an American lymphoma: Preliminary note, J. Natl. Cancer Inst. 35:899–903.Google Scholar
  129. Ohno, S., Luka, J., Lindahl, T., and Klein, G., 1977, Identification of a purified Complement-fixing antigen as the EBV determined nuclear antigen (EBNA/ by its binding to metaphase Chromosomes, Proc. Natl. Acad. Sci. U.S.A. 74:1605–1609.PubMedGoogle Scholar
  130. Ohno, S., Luka, J., Falk, L., and Klein, G., 1978, Serologic reactivities of human and baboon sera against EBNA and herpes virus papio determined nuclear antigen, Eur. J. Cancer 14:955–960.PubMedGoogle Scholar
  131. Ohno, S., Luka, F., Falk, L., and Klein, G., 1979, Detection of a nuclear, EBNA-type antigen in apparently EBNA negative herpesvirus papio (HVP)-transformed lymphoid lines by the acid fixed nuclear binding technique, Int. J. Cancer 20:941–946.Google Scholar
  132. Orellana, T., and Kieff, E., 1977, Epstein-Barr virus specific RNA. II. Analysis of polyaden-ylated viral RNA in restringent, abortive and productive infection, J. Virol. 22:321–330.PubMedGoogle Scholar
  133. Pagano, J.S., and Huang, C-H., 1976, Epstein-Barr virus genome in infectious mononucleosis, Nature (London) 263:787–789.Google Scholar
  134. Pagano, J.S., Huang, C-H., Klein, G., de Thé, G., Shanmugaratnam, K., and Yang, C-S., 1975, Homology of Epstein-Barr virus DNA in nasopharyngeal Carcinomas from Kenya, Taiwan, Singapore and Tunisia, in: Oncogenesis and Herpesviruses II (G. de Thé, M.A. Epstein, and H. zur Hausen, eds.), pp. 179–190, IARC Scientific Publication No. 11, Lyon.Google Scholar
  135. Pearson, G., and Qualtière, L., 1978, Papain solubilization of the Epstein-Barr virus induced membrane antigen, J. Virol. 28:344–351.PubMedGoogle Scholar
  136. Pizzo, P.A., Magrath, LT., Chattopadhyay, S.K., Biggar, R.J., and Gerber, P., 1978, A new tumor-derived transforming strain of Epstein-Barr virus, Nature (London) 272:629–631.Google Scholar
  137. Pope, J., Achong, B., and Epstein, M., 1968a, Cultivation and pure structure of virus bearing lymphoblasts from a second New Guinea Burkitt lymphoma, Int. J. Cancer 3:171–182.PubMedGoogle Scholar
  138. Pope, F., Home, M., and Scott, W., 1968b, Transformation of fetal human leukocytes in vitro in filtrates of a human leukaemic Cell line Containing herpes-like virus, Int. J. Cancer 3:857–866.PubMedGoogle Scholar
  139. Pope, J.H., Scott, W., Reedman, B.M., and Water, M.K., 1971, EB virus as a biologically active agent, in: Recent Advances in Human Tumor Virology and Immunology (W. Nakahara, K. Nishioka, T. Hirayama, and Y. Ito, eds., pp. 177–188, University of Tokyo Press, Tokyo.Google Scholar
  140. Powell, A.L.T., King, W., and Kieff, E., 1979, Epstein-Barr virus specific RNA. III. Mapping of the DNA encoding viral specific RNA in restringently infected cells, J. Virol. 29:261–274.PubMedGoogle Scholar
  141. Pritchett, R.F., Hayward, S.D., and Kieff, E., 1975a, DNA of Epstein-Barr virus. I. Comparison of DNA of virus purified from HR-1 and B95–8 cells, J. Virol. 15:556–569.PubMedGoogle Scholar
  142. Pritchett, R.F., Hayward, S.D., and Kieff, E., 1975b, Analysis of the DNA of Epstein-Barr viruses and transcriptional products in “transformed cells, in: Oncogenesis and Herpesviruses (H. zur Hausen, G. de Thé, and M. Epstein, eds.), pp. 177–191, IARC Monograph, Lyon.Google Scholar
  143. Pritchett, R., Pedersen, M., and Kieff, E., 1976, Complexity of EBV homologous DNA in Continuous lymphoblastoid Cell lines, Virology 74:227–231.Google Scholar
  144. Qualtière, L., and Pearson, G., 1979, Epstein-Barr virus induced membrane antigens: Im-muno-chemical Characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells, Int. J. Cancer 23:808–817.PubMedGoogle Scholar
  145. Qualtière, L., and Pearson, G., 1980, Radioimmune precipitation study Comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus superinfected Raji cells to those expressed on cells in a B95–8 virus transformed producer Culture activated with tumor promoting agent (TPA), Virology 102:360–369.PubMedGoogle Scholar
  146. Raab-Traub, N., Pritchett, R., and Kieff, E., 1978, DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments which Contain DNA sequences which differ among strains of EBV, J. Virol. 27:388–398.PubMedGoogle Scholar
  147. Raab-Traub, N., Dambaugh, T., and Kieff, E., 1980, DNA of Epstein-Barr virus. VIII. B95–8, the previous prototype, is an unusual deletion derivative, Cell 22:257–267.PubMedGoogle Scholar
  148. Rabin, H., Neubauer, R., Hopkins, F., and Nonoyama, M., 1978, Further Characterization of a herpes virus-positive orangutan Cell line and Comparative aspects of in vitro transformation with lymphotropic Old World primate herpesviruses, Int. J. Cancer 21:762–767.PubMedGoogle Scholar
  149. Rabin, H., Strnad, B.C., Neubauer, R.H., Brown, A.M., Hopkins, R.F., and Mazur, R.A., 1980, Comparisons of nuclear antigens of Epstein-Barr virus (EBV) and EBV-like simian viruses, J. Gen. Virol. 48:265–272.PubMedGoogle Scholar
  150. Ragona, G., Ernberg, I., and Klein, G., 1980, Induction and biological Characterization of the Epstein-Barr virus (EBV) Carried by the Jijoye lymphoma line, Virology 101:553–557.PubMedGoogle Scholar
  151. Reedman, B.M. and Klein, G., 1973, Cellular localization of an Epstein-Barr virus (EBV)-associated Complement-fixing antigen in producer and non-producer lymphoblastoid Cell lines, Int. J. Cancer 11:499–520.PubMedGoogle Scholar
  152. Reedman, B.M., Klein, G., Pope, J.H., Walters, M.K., Hilgers, J., Singh, S., and Johansson, B., 1974, Epstein-Barr virus-associated Complement-fixing and nuclear antigens in Burkitt lymphoma biopsies, Int. J. Cancer 13:755–763.PubMedGoogle Scholar
  153. Robinson, J., Smith, D., and Niederman, J., 1981, Plasmacytic differentiation of Circulating EBV infected B lymphocytes during acute infectious mononucleosis, J. Exp. Med. 153:235–244.PubMedGoogle Scholar
  154. Rymo, L., 1979, Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells, J. Virol. 32:8–18.PubMedGoogle Scholar
  155. Rymo, L., and Forsblum, S., 1978, Cleavage of Epstein-Barr virus DNA by restriction en-donucleases EcoRI, Hind III and Bam I, Nucleic Acid Res. 5:1387–1402.PubMedGoogle Scholar
  156. Shaw, J., Seebeck, T., Li, J.-L., and Pagano, J., 1977, Epstein-Barr virus DNA synthesized in superfected Raji cells, Virology 77:762–771.PubMedGoogle Scholar
  157. Shope, T., Dechairo, D., and Miller, G., 1973, Malignant lymphoma in Cotton-top marmosets following inoculation of Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 10:2487–2491.Google Scholar
  158. Siegel, P., Clough, W., and Strominger, J., 1981, Sedimentation Characteristics of newly synthesized Epstein-Barr virus viral DNA in superinfected cells, J. Virol. 38:880–885.PubMedGoogle Scholar
  159. Skare, J., and Strominger, F., 1980, Cloning and mapping of Bam HI endonuclease fragments from the transforming B95–8 strain of Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 77:3860–3864.PubMedGoogle Scholar
  160. Slovin, S., Vaughan, J., and Carson, D., 1980, Expression of EBNA and RANA during different phases of the Cell growth Cycle, Int. J. Cancer 26:9–15.PubMedGoogle Scholar
  161. Slovin, S., Glassy, M., Dambaugh, T., Catalano, M., Curry, R., Ferrone, S., Kieff, E., Vaughan, J., and Carson, D., 1981, Discordant expression of two Epstein-Barr virus associated antigens EBNA and RANA in man-rodent somatic Cell hybrids, J. Immunol. 127:585–590.PubMedGoogle Scholar
  162. Spear, P., 1980, Composition and organization of herpes virus virions and properties of some of the structural proteins, in: Oncogenic and Herpesviruses, Vol. 1 (F. Rapp, ed.), CRC Press, Baca Raton, Florida.Google Scholar
  163. Stevens, D.A., Pry, T.W., Blackman, E.A., and Manaker, R.A., 1970, Comparison of antigens from human and Chimpanzee herpes-type virus-infected hemic Cell lines, Proc. Soc. Exp. Biol. Med. 133:678–683.PubMedGoogle Scholar
  164. Stewart, S., Lovelace, E., Whang, J., and Ngu, V., 1965, Burkitt tumor, tissue Culture, Cytogenetic and viral studies, J. Natl. Cancer Inst. 34:319–328.PubMedGoogle Scholar
  165. Strnad, B., Neubauer, R., Rabin, H., and Mazur, R., 1979, Correlation between EBV membrane antigen and three large Cell surface glycoproteins, J. Virol. 32:885–894.PubMedGoogle Scholar
  166. Strnad, B., Schuster, T., Hopkins, R., Neubauer, R., and Rabin, H., 1981, Identification of an EBV nuclear antigen by fluoroimmuno-electrophoresis and radioimmunoelectro-phoresis, J. Virol. 38:996–1004.PubMedGoogle Scholar
  167. Sugden, B., and Mark, W., 1977, Clonal transformation of adult human leukocytes by Epstein-Barr virus, J. Virol. 23:503–508.PubMedGoogle Scholar
  168. Sugden, B., Summers, W.C., and Klein, G., 1976, Nucleic acid renaturation and restriction endonuclease Cleavage analyses show that the DNAs of a transforming and non-transforming strain of Epstein-Barr virus share approximately 90% of their nucleotide sequences, J. Virol. 18:765–775.PubMedGoogle Scholar
  169. Sugden, B., Phelps, M., and Domoradzki, J., 1979, EBV DNA is amplified in transformed lymphocytes, J. Virol. 31:590–595.PubMedGoogle Scholar
  170. Summers, W., and Klein, G., 1976, Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid, J. Virol. 18:151–155.PubMedGoogle Scholar
  171. Svedmyr, E., and Jondal, M., 1975, Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis, Proc. Natl. Acad. Sci. U.S.A. 72:1622–1666.PubMedGoogle Scholar
  172. Tanaka, A., Nonoyama, M., and Glaser, R., 1977, Transcription of latent Epstein-Barr virus genomes in human epithelial/Burkitt hybrid cells, Virology 82:63–68.PubMedGoogle Scholar
  173. Thorley-Lawson, D., 1979, Characterization of Cross-reacting antigens on the EBV envelope and plasma membranes of producer cells, Cell 16:33–42.PubMedGoogle Scholar
  174. Thorley-Lawson, D., and Edson, C., 1979, Polypeptides of the EBV membrane antigen Complex, J. Virol. 32:458–467.PubMedGoogle Scholar
  175. Thorley-Lawson, D., and Geilinger, K., 1980, Monoclonal antibodies against the major glycoprotein (gp 350/220) of EBV neutralize infectivity, Proc. Natl. Acad. Sci. U.S.A. 77:5307–5311.PubMedGoogle Scholar
  176. Thorley-Lawson, D., and Strominger, J.L., 1976, Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid, Nature (London) 263:332–334.Google Scholar
  177. Toplin, I., and Schidlovsky, G., 1966, Partial purification and electron microscopy of the virus in the EB-3 Cell line derived from a Burkitt lymphoma, Science 152:1084–1085.PubMedGoogle Scholar
  178. Van Santen, V., Cheung, A., and Kieff, E., 1981, Epstein-Barr virus (EBV) RNA. VII. Viral Cytoplasmic RNA in a restringently infected Cell line transformed in vitro by EBV, Proc. Natl. Acad. Sci. U.S.A. 78:1930–1934.PubMedGoogle Scholar
  179. Volsky, D.J., Shapiro, I.M., and Klein, G., 1980, Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression, Proc. Natl. Acad. Sci. U.S.A. 77(9):5453–5457.PubMedGoogle Scholar
  180. Wagner, E.K., Roizman, B., Savage, T., Spear, P., Mizell, M., Darr, F., and Sypowicz, D., 1970, Characterization of the DNA of the herpesvirus associated with Lucke adenocarcinoma of the frog and Burkitt lymphoma of man, Virology 42:257–261.PubMedGoogle Scholar
  181. Wolf, H., zur Hausen, H., Klein, G., Becker, Y., Henle, G., and Henle, W., 1975, Attempts to detect virus-specific DNA sequences in human tumors. III. EBV DNA in nonlym-phoid nasopharyngeal Carcinoma cells, Med. Microbiol. Immunol. 161:15–21.PubMedGoogle Scholar
  182. Yajima, Y., and Nonoyama, M., 1976, Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of non-infectious virus particles in superinfected Raji cells, J. Virol. 19:187–194.PubMedGoogle Scholar
  183. Yajima, Y., Marczynska, B., and Nonoyama, M., 1978, Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells, Proc. Natl. Acad. Sci. U.S.A. 75:2008–2010.PubMedGoogle Scholar
  184. Yamamoto, N., and Hinuma, Y., 1976, Clonal transformation of human leukocytes by Epstein-Barr virus in soft agar, Int. J. Cancer 17:191–196.PubMedGoogle Scholar
  185. Zur Hausen, H., and Schulte-Holthausen, H., 1970, Presence of EB virus nucleic acid homology in a “virus free” line of Burkitt’s tumor cells, Nature (London) 227:245–248.Google Scholar
  186. Zur Hausen, H., Schulte-Holthause, H., Klein, G., Henle, W., Henle, G., Clifford, P. and Santesson, L., 1970, EB virus DNA in biopsies of Burkitt tumors and anaplastic Carcinomas of the nasopharynx, Nature (London) 228:1056–1057.Google Scholar
  187. Zur Hausen, H., Diehl, V., Wolf, H., Schulte-Holthausen, H., and Schneider, U., 1972, Occurrence of Epstein-Barr virus genomes in human lymphoblastoid Cell lines, Nature (London) Biol. 237:189–190.Google Scholar
  188. Zur Hausen, H., O’Neill, F.J., and Freese, U., 1978, Persisting oncogenic herpesvirus induced by the tumor promotor TPA, Nature (London) 272:373–375.Google Scholar
  189. Zur Hausen, H., Bornkamm, G., Schmidt, R., and Hecker, E., 1979, Tumor initiators and promotors in the induction of EBV, Proc. Natl. Acad. Sci. U.S.A. 76:782–785.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Elliott Kieff
    • 1
  • Timothy Dambaugh
    • 1
  • Walter King
    • 1
  • Mark Heller
    • 1
  • Andrew Cheung
    • 1
  • Vicky Van Santen
    • 1
  • Mary Hummel
    • 1
  • Christopher Beisel
    • 1
  • Susan Fennewald
    • 1
  1. 1.Division of Biological SciencesThe University of ChicagoChicagoUSA

Personalised recommendations